Evofem announces Emirati health care filed application with UAE MOHAP
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 23 2025
0mins
Approval Application: Pharma 1 Drug Store LLC has submitted an application to the UAE Ministry of Health and Prevention to commercialize PHEXXI, Evofem's FDA-approved hormone-free contraceptive.
Market Demand: The CEO of Pharma 1 highlights a growing demand for hormone-free contraception in the UAE, anticipating strong reception from OB/GYNs and women once the product is launched.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
